More on PRQR
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.45 |
|
|||
| Open | $1.45 | ||||
| 52 Wk High | $13.33 | ||||
| 52 Wk Low | $3.48 | ||||
| Day High | $1.49 | ||||
| Day Low | $1.30 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,064,240 | ||||
- ProQR Therapeutics N.V. (PRQR) PT Lowered to $8 at H.C. Wainwright
- ProQR Therapeutics N.V. (PRQR) Reiterated at Market Outperform by Citizens Ahead of Ph1 Readouts
- Form 6-K ProQR Therapeutics N.V. For: Sep 23
- ProQR names new AI chief and adds Hugging Face co-founder to board
- ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor
- ProQR doses first participant in Phase 1 trial of AX-0811
- ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026
- ProQR to Participate in Upcoming Investor Conferences in September 2026
- BofA Securities Starts ProQR Therapeutics N.V. (PRQR) at Buy
- H.C. Wainwright Reiterates Buy Rating on ProQR Therapeutics N.V. (PRQR)
Entities mentioned with PRQR
- FDA | View Related Stories »
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Citi | View Related Stories »
- Chardan Capital Markets | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- JMP Securities | View Related Stories »
- Show More...
